Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., is a biotechnology company focused on delivering innovative therapies in areas of critical care and infectious diseases. The company’s product portfolio includes the first and only antibiotic developed specifically for the treatment of Acinetobacter pathogens in adults. For more information, visit www.innovivaspecialtytherapeutics.com.